Use of sodium channel blocking compounds and aspirin in...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/616 (2006.01) A61K 31/519 (2006.01) A61P 25/04 (2006.01) A61P 29/00 (2006.01) A61K 31/517 (2006.01)

Patent

CA 2493885

This invention relates to the use of combinations of a sodium channel blocking compound that binds to an SS1 or SS2 site of extracellular region of a sodium channel alpha subunit, and aspirin in manufacturing drugs for producing synergistically analgesic effect in mammals. Pharmaceutical compositions based upon this invention can enhance analgesic effect and reduce dosage of aspirin, therefore side effects and adverse reactions are decreased accordingly.

La présente invention concerne l'utilisation de combinaisons de composés bloquant les canaux sodiques et d'aspirine dans la production de médicaments destinés à obtenir un effet analgésique synergique chez des mammifères, chez qui lesdits composés se fixent à la sous-unité alpha des sites SS1 ou SS2 dans le canal sodique. Selon l'invention, les compositions pharmaceutiques ont un effet analgésique accru et par conséquent la posologie de l'aspirine ainsi que ses effets secondaires seraient réduits.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of sodium channel blocking compounds and aspirin in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of sodium channel blocking compounds and aspirin in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sodium channel blocking compounds and aspirin in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2088001

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.